Followers | 4047 |
Posts | 152910 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |

Tuesday, January 30, 2024 7:54:36 AM
Recent ITRM News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 11:15:25 AM
- Iterum Therapeutics Announces Partnership for Commercialization Services • GlobeNewswire Inc. • 06/11/2025 11:00:00 AM
- Iterum Therapeutics Announces Extension of Term of Promissory Note • GlobeNewswire Inc. • 05/19/2025 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:30:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:15:09 AM
- Iterum Therapeutics Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 • GlobeNewswire Inc. • 05/06/2025 11:00:00 AM
- Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/30/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 01:16:27 AM
- Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/29/2025 12:00:00 PM
- Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics • GlobeNewswire Inc. • 04/14/2025 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 12:35:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2025 05:15:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:49:20 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/07/2025 09:33:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/07/2025 12:30:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 12:15:07 PM
- Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 02/07/2025 12:00:00 PM
- Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 • GlobeNewswire Inc. • 01/31/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 11:30:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/10/2024 12:04:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 02:15:44 PM
- Iterum Therapeutics Regains Full Nasdaq Compliance • GlobeNewswire Inc. • 11/21/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 12:30:29 PM
FEATURED MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness • Jun 24, 2025 8:45 AM
FEATURED Envirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem • Jun 24, 2025 8:42 AM
Avant Technologies Creating New Company for Expansion of Diabetes Program • AVAI • Jun 24, 2025 8:00 AM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM